QR Code

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience

Abstract Background As prognosis of patients with metastatic hepatocellular carcinoma (HCC) is mainly determined by intrahepatic HCC progression, local treatment with TACE may result in improved OS, although it is not recommended. The purpose of this study was to analyze retrospectively the efficacy...

Description complète

Enregistré dans:
Auteurs principaux: Dominik Bettinger, Renan Spode, Nicolas Glaser, Nico Buettner, Tobias Boettler, Christoph Neumann-Haefelin, Thomas Baptist Brunner, Eleni Gkika, Lars Maruschke, Robert Thimme, Michael Schultheiss
Format: Artigo
Langue:Inglês
Publié: BMC 2017-08-01
Collection:BMC Gastroenterology
Sujets:
Hepatocellular carcinoma
Metastases
Sorafenib
Transarterial chemoembolization
Prognosis
Accès en ligne:http://link.springer.com/article/10.1186/s12876-017-0656-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires